News for 'Pharma'

Kejriwal's arrest: INDIA plans mega rally on March 31

Kejriwal's arrest: INDIA plans mega rally on March 31

Rediff.com24 Mar 2024

The opposition's Indian National Developmental Inclusive Alliance (INDIA) will hold a 'maha rally' at Delhi's Ramlila Maidan on March 31 to safeguard the country's interests and democracy, Aam Aadmi Party leader Gopal Rai said on Sunday.

'Investor migration in IT and pharma will stay for a while'

'Investor migration in IT and pharma will stay for a while'

Rediff.com23 Dec 2020

'Quality of management, corporate governance, allocation of capital, full disclosures should form the basis to decide investing in a particular stock.'

Looking For Long-Term Investment?

Looking For Long-Term Investment?

Rediff.com19 Apr 2024

This is a good opportunity for long-term investors to pick quality small and midcap stocks at reasonable valuations.

Daiichi Sankyo to offload stake in Sun Pharma

Daiichi Sankyo to offload stake in Sun Pharma

Rediff.com20 Apr 2015

Daiichi won't remain a major shareholder in Sun Pharma.

Pharma stocks on a booster dose

Pharma stocks on a booster dose

Rediff.com1 Mar 2014

Better-than-expected financial results in Q3 due to higher revenue growth and margins in key markets fuel the rally

3 employees of Noida pharma arrested in Uzbek cough syrup death case

3 employees of Noida pharma arrested in Uzbek cough syrup death case

Rediff.com3 Mar 2023

Three employees of a Noida-based pharmaceutical firm, whose cough syrup is alleged to have led to the death of 18 children in Uzbekistan last year, were arrested on charges of manufacturing and sale of adulterated drugs, officials said.

Pharma sector can be a good bet

Pharma sector can be a good bet

Rediff.com17 Nov 2015

Analysts say those taking exposure through stocks could look at firms focused on domestic business

China moved military forces in disregard of agreements: Jaishankar

China moved military forces in disregard of agreements: Jaishankar

Rediff.com27 Feb 2024

The external affairs minister, speaking at a media summit organised by the TV9 Network, described the rise of India and China as "significant" in the global geopolitical scenario.

Mutual funds turn upbeat on health care sector, divided on IT prospects

Mutual funds turn upbeat on health care sector, divided on IT prospects

Rediff.com25 Jul 2023

Mutual funds (MFs) are betting on a turnaround in the healthcare sector to boost returns but are divided on the prospects of the information technology (IT) sector amid uncertain growth outlook. At the end of June, all of the top 20 fund houses were overweight on the healthcare sector vis--vis the sector's presence in the BSE 200 index, shows a report by Motilal Oswal Financial Services (MOFS). In the case of the IT sector, only six of the 20 fund houses had overweight positions.

Gas leak at pharma plant in Vizag leaves 2 dead

Gas leak at pharma plant in Vizag leaves 2 dead

Rediff.com30 Jun 2020

The leakage of benzimidazole gas occurred at Sainor Life Sciences Pvt Ltd in Visakhapatnam on Monday night.

'I failed 2 start-ups and lost Rs 2 crores. Pls help'

'I failed 2 start-ups and lost Rs 2 crores. Pls help'

Rediff.com22 Nov 2023

rediffGURU Chandu Nair advises entrepreneurs and enterprises about how to create and build their business.

Kavitha spends night at ED office, to be taken to court today

Kavitha spends night at ED office, to be taken to court today

Rediff.com16 Mar 2024

Bharat Rashtra Samiti leader K Kavitha is expected to be produced before a special Prevention of Money Laundering Act (PMLA) court by the Enforcement Directorate in New Delhi on Saturday for obtaining her remand for custodial interrogation in the money laundering case linked to alleged irregularities in the scrapped Delhi excise policy 2021-22, officials said.

At Rs 35 a pill, Sun Pharma's FluGuard is the cheapest favipiravir drug

At Rs 35 a pill, Sun Pharma's FluGuard is the cheapest favipiravir drug

Rediff.com5 Aug 2020

Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease.

Electoral bonds: Congress flags mismatch in donor, recipient files

Electoral bonds: Congress flags mismatch in donor, recipient files

Rediff.com15 Mar 2024

It also asked why the data shared pertained to a period from April 2019 even though the scheme for anonymous political funding was introduced in 2017.

India Inc capital expenditure story gets cement to semiconductor push

India Inc capital expenditure story gets cement to semiconductor push

Rediff.com19 Apr 2024

Corporate India is starting to step up its capital expenditure plans amid government incentives and signs of rising demand, company executives and analysts have indicated. This coincides with the Reserve Bank of India (RBI) recently citing a double-digit growth in private capital expenditure. Healthy balance sheets of banks and corporates, along with increasing capacity utilisation and improving business sentiment, are contributing to a favourable environment for sustained growth in private sector investments, the RBI said in its policy last week.

'Small, mid-caps attractive long-term'

'Small, mid-caps attractive long-term'

Rediff.com26 Mar 2024

'Given the inherent volatility, investors should take at least a three to five-year view.'

Excise policy: AAP's Goa poll kickbacks detected in I-T, CBI probes, says ED

Excise policy: AAP's Goa poll kickbacks detected in I-T, CBI probes, says ED

Rediff.com31 Mar 2024

Statements of five 'Angadiya' firm operators have also been recorded by the ED to establish the "money trail" of this alleged Rs 45 crore bribe amount.

BSE, NSE settle with marginal gains in volatile trade

BSE, NSE settle with marginal gains in volatile trade

Rediff.com30 Nov 2023

Benchmark equity indices Sensex and Nifty settled with marginal gains on Thursday in a highly volatile trade amid the scheduled monthly derivatives expiry and muted trend in the US markets. The 30-share BSE Sensex closed 86.53 points or 0.13 per cent higher at 66,988.44, registering its third day of gains. During the day, it hit a high of 67,069.89 and a low of 66,610.35.

EC reveals electoral bond donors, but not who gave which party

EC reveals electoral bond donors, but not who gave which party

Rediff.com15 Mar 2024

From steel tycoon Lakshmi Mittal to billionaire Sunil Bharti Mittal's Airtel, Anil Agarwal's Vedanta, ITC, Mahindra and Mahindra, and a lesser-known Future Gaming and Hotel Services were among the prominent buyers of the now-scrapped electoral bonds for making political donations.

Why Daiichi's exit is good for Sun Pharma

Why Daiichi's exit is good for Sun Pharma

Rediff.com22 Apr 2015

But splitting management bandwidth by investing in non-core businesses will not be appreciated by the market in the long run.

India overtakes Hong Kong as world's fourth-largest stock market

India overtakes Hong Kong as world's fourth-largest stock market

Rediff.com23 Jan 2024

Benchmark indices--Sensex and Nifty--were 0.7-0.8 per cent higher from the Saturday closing. Among the widely-tracked Nifty 50 stocks, 39 advanced and the rest 11 declined at the opening bell. Among the individual stocks, Cipla, ICICI Bank, Sun Pharma, Power Grid Corp, and Bharti Airtel were the top five gainers, while Asian Paints, Hindustan Unilever, Britania, HDFC Bank, and BPCL the losers, NSE data showed. On Monday, Indian stock exchanges were closed for trading on the occasion of Pran Pratistha of Ram Temple in Ayodhya.

Pharma co mired in syrup deaths shuts production at Noida unit

Pharma co mired in syrup deaths shuts production at Noida unit

Rediff.com30 Dec 2022

The move has come days after the state government announced to form a special investigation team to probe into the death of Disha Salian, the former manager of late actor Sushant Singh Rajput.

FDI in pharma doubled during April-August

FDI in pharma doubled during April-August

Rediff.com18 Nov 2013

FDI in drugs and pharmaceuticals was $487 million during April-August 2012, according to the latest data of the Department of Industrial Policy and Promotion.

Pharma industry posts 51.5% growth in April sales

Pharma industry posts 51.5% growth in April sales

Rediff.com8 May 2021

When compared to the domestic sales of April 2019, the growth is around 37 per cent. However, compared to the previous month (March), the growth is 18.4 per cent.

India-EFTA trade pact: How Swiss firms stand to gain

India-EFTA trade pact: How Swiss firms stand to gain

Rediff.com10 Mar 2024

Domestic customers will get access to high-quality Swiss products such as watches, chocolates, biscuits, and clocks at lower prices as India will phase out customs duties under its trade pact with the EFTA bloc on these goods over a period of time. India and the four-European nation bloc EFTA signed a trade and economic partnership agreement (TEPA) on Sunday to boost trade and investments between the two regions. The European Free Trade Association (EFTA) members are Iceland, Liechtenstein, Norway, and Switzerland.

India, EFTA sign $100-billion free trade pact

India, EFTA sign $100-billion free trade pact

Rediff.com10 Mar 2024

Domestic customers will get access to high-quality Swiss products such as watches, chocolates, biscuits, and clocks at lower prices as India will phase out customs duties under its trade pact with the EFTA bloc on these goods over a period of time. India and the four-European nation bloc EFTA signed a trade and economic partnership agreement (TEPA) on Sunday to boost trade and investments between the two regions. The European Free Trade Association (EFTA) members are Iceland, Liechtenstein, Norway, and Switzerland.

PharmEasy buys Medlife, becomes largest e-pharma company

PharmEasy buys Medlife, becomes largest e-pharma company

Rediff.com26 May 2021

PharmEasy has acquired Medlife for an undisclosed amount, the e-pharmacy unicorn said on Tuesday. The deal will make PharmEasy the largest player in the domestic online pharmacy sector, with the combined entity set to serve 2 million customers a month.

What is ailing India's pharma sector?

What is ailing India's pharma sector?

Rediff.com18 Aug 2016

Low growth visibility and trouble with regulators have resulted in lack of interest from investors

'Kejriwal has outlived his utility for the BJP'

'Kejriwal has outlived his utility for the BJP'

Rediff.com23 Mar 2024

'The BJP was supporting him from behind in order to bring down the Congress government.'

Indian drug firm recalls eye drop linked to vision loss in US

Indian drug firm recalls eye drop linked to vision loss in US

Rediff.com3 Feb 2023

Global Pharma Healthcare is recalling entire lots of eye drop linked to vision loss in the US, according to the US Food and Drug Administration. The Chennai-based company is recalling all lots of artificial tears lubricant eye drops distributed by EzriCare, LLC and Delsam Pharma to the consumer level due to possible contamination, the US health regulator said in a statement. "The Centres for Disease Control and Prevention (CDC) alerted FDA to an investigation of a multi-state cluster of Verona Integron-mediated Metallo--lactamase (VIM)- and Guiana-Extended Spectrum--Lactamase (GES)- producing carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) infections possibly associated with the use of the artificial tears manufactured by Global Pharma Healthcare," USFDA said.

Sun Pharma surpasses SBI in market valuation

Sun Pharma surpasses SBI in market valuation

Rediff.com17 Mar 2015

TCS is the most valued Indian company.

Covid vaccine: Pharma firms ready expansion plans

Covid vaccine: Pharma firms ready expansion plans

Rediff.com6 Oct 2020

The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred million doses of the product at a certain price.

Are Indian Markets Overstretched?

Are Indian Markets Overstretched?

Rediff.com27 Feb 2024

The index is currently trading at 149 per cent of its historical P/B valuation, surpassing its previous peak of 125 per cent made in 2020-21.

Sensex plunges 551 points on sluggish global trends

Sensex plunges 551 points on sluggish global trends

Rediff.com18 Oct 2023

Among the Sensex firms, Bajaj Finance fell by nearly 3 per cent, the most among the 30 frontline companies. Bajaj Finserv, Axis Bank, HDFC Bank, Reliance Industries, NTPC, ICICI Bank and IndusInd Bank were the other major laggards. In contrast, Tata Motors, Sun Pharma, Maruti and Mahindra & Mahindra were the gainers.

Stock markets rebound; Sensex jumps 490 points

Stock markets rebound; Sensex jumps 490 points

Rediff.com2 Nov 2023

Among the Sensex firms, IndusInd Bank, Tata Steel, Tata Motors, Sun Pharma, Infosys, Mahindra & Mahindra, Infosys, NTPC, Bharti Airtel, HCL Technologies and Axis Bank were the biggest gainers. Tech Mahindra and Bajaj Finance were the laggards.

Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma

Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma

Rediff.com22 Apr 2015

The company sold over 21 crore (210 million) shares in Sun Pharma.

Sensex up 276 points; banking, metal shares shine

Sensex up 276 points; banking, metal shares shine

Rediff.com21 Nov 2023

Among the Sensex firms, JSW Steel, Titan, Tata Steel, Sun Pharma, Reliance Industries, Bharti Airtel, Tata Motors and HDFC Bank were the biggest gainers. NTPC, Tech Mahindra, Maruti, State Bank of India and Larsen & Toubro were among the laggards.

HC upholds Kejriwal's arrest, says law applies equally to all

HC upholds Kejriwal's arrest, says law applies equally to all

Rediff.com9 Apr 2024

In a massive setback to Delhi Chief Minister Arvind Kejriwal, the Delhi high court on Tuesday dismissed his petition challenging his arrest in a money laundering case stemming from the alleged excise scam, saying there was no contravention of legal provisions.

US drug shortage a shot in the arm for Indian pharmaceutical companies

US drug shortage a shot in the arm for Indian pharmaceutical companies

Rediff.com26 Jun 2023

Drug shortages in the US are at an all-time high, and price erosion has stabilised, which could benefit Indian pharmaceutical (pharma) companies with a US focus, according to analysts. Nuvama Research analysts said that US price erosion seems to have normalised to its old levels of 6-8 per cent and volumes are picking up with easing of inventory. Similarly, an ICICIdirect analyst noted: "Price erosion intensity has now moderated to a single digit and is expected to tone down a

Electoral bonds: Who is lottery king Santiago Martin?

Electoral bonds: Who is lottery king Santiago Martin?

Rediff.com15 Mar 2024

Future Gaming and Hotel Services whose director is the lottery magnate Santiago Martin is the top purchaser of electoral bonds having purchased bonds worth Rs 1,368, according to data uploaded by the Election Commission of India on its website on Thursday.